Using pharmacotherapy to address sleep disturbances in autism spectrum disorders-Reference-Cited by-同舟云学术

Using pharmacotherapy to address sleep disturbances in autism spectrum disorders

Published:2023-10-11 Issue:12 Volume:23 Page:1261-1276
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Mammarella Valeria¹,Orecchio Silvia¹,Cameli Noemi¹,Occhipinti Sara¹,Marcucci Lavinia¹,De Meo Giuliano¹,Innocenti Alice¹,Ferri Raffaele²,Bruni Oliviero³^ORCID

Affiliation:

1. Child Neuropsychiatry Unit, Department of Human Neuroscience, Sapienza University, Rome, Italy

2. Sleep Research Centre, Oasi Research Institute - IRCCS, Troina, Italy

3. Department of Social and Developmental Psychology, Sapienza University, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2023.2267761

Reference160 articles.

1. Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders

2. Sleep in Children with Autism Spectrum Disorder

3. Global prevalence of autism: A systematic review update

4. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018

5. Management of sleep disorders among children and adolescents with neurodevelopmental disorders: A practical guide for clinicians

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insomnia in children affected by autism spectrum disorder: The role of melatonin in treatment;Sleep Medicine;2024-07

2. Developmental alcohol exposure is exhausting: Sleep and the enduring consequences of alcohol exposure during development;Neuroscience & Biobehavioral Reviews;2024-03